FDA NDC Directory · JSON-LD · Markdown

Sodium phenylacetate and Sodium benzoate

NDC 70710-1926 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA217526
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsSODIUM BENZOATE (100 mg/mL)
SODIUM PHENYLACETATE (100 mg/mL)
Marketing started20230919
Package count1

External sources

Source: openFDA. Public-domain (CC0).